Bepridil
At a glance
- Drug Originator RETI
- Drug Licenced by Daiichi Sankyo Company; Meda Pharmaceuticals; Merck & Co; Organon Italia; Ortho-McNeil
- Drug Class Class IV antiarrhythmics; Ischaemic heart disorder therapies; Pyrrolidines; Small molecules
- Mechanism of Action Calcium channel antagonists; Calmodulin antagonists; Potassium channel antagonists; Sodium channel antagonists
- USA Patent Applicants JOHNSON AND JOHNSON
- USA Patents 1
- NDAs 1
- Patent Applications 761
Table of Contents
Disclaimer